Chronic Therapy Startup with just 5 products in 1983 Sales were initially limited to 2 states West Bengal and

Bihar. leading pharmacy company in India. Sun Pharma owns approx 76% on a diluted basis of the outstanding common shares of Caraco. Headquarter in Mumbai. Sun Pharma has two R&D centers in Baroda and Mumbai.

 Sun Pharma was listed on the main stock exchanges in India in 1994. It currently markets 58 products and had reported a turnover of Rs.222 mill with a profit of Rs.49 mill for the year ending March 09. The Rs 55 crore issue of a Rs. 10 face value equity share at a premium of Rs. 140/- was oversubscribed 55 times. 8000 employees. 2 World class research centers. 60% of sales from international markets.

Particular

20012002 7552

20022003 9812

20032004 9995

20042005 12301

20052006 18042

20062007 23745

20072008 35017

20082009 44808

Total income

Profit after tax

1707

2444

3446

4002

5630

8402

15509

18780

Reserve and surplus Earning per share( in rupees) Investment

4596

5141

7540

10366

14959

26747

48879

69414

35.6

26.4

35.4

21.3

30.9

41.7

74.7

87.8

818

38

1765

6485

3541

2543

6565

18595

31STMARCH 09 RESERVES AND SURPLUS Capital reserveAs per last balance sheet Securities premium Account As per last balance sheet Add-received during the year Capital redemption reserve As per last balance sheet Add transferred from profit and loss account General reserve As per last balance sheet Add transferred from profit and loss account Surplus as per profit and loss A/c 14240.00 4500.00 18740 16225.9 50478.6 154.5 154.5 15099.1 15099.1 259.1 RS IN MILLION RS IN MILLION

31st MARCH 08 RS IN MILLION RS IN MILLION 259.1 5165.9 9933.2 140.8 13.7 154.5 15099.1

11240 3000 14240 11287.9 41040.6

Your Directors take pleasure in presenting the Seventeenth Annual Report and Audited Accounts for the year ended 31st March, 2009. (Rs. in million except book value and dividend per share)

Financial results
Total income Profit after tax Dividend on preference share

31st march,2009
40437 12653 0

31st march,2008
32767 10140 1

Dividend on equity share

Corporate dividend tax Transfer to various reserves Amount of dividend per equity share of Rs. 5 each Book value per equity share of Rs.5 each

2848
484 4500 13.75 249

2175
372 3014 10.50 203

DIVIDEND
Your Directors are pleased to recommend an equity dividend of Rs.13.75 per equity share of face value Rs.5/- each (previous year Rs.10.50 per equity share of face value Rs.5/- each)for the year ended 31st March, 2009.

BONUS SHARES
161,630,010 Equity shares were allotted as fully paid Bonus Shares by capitalization of Securities Premium Account, Profit and Loss Account, Amalgamation Reserve and Capital Redemption Reserve Account, without payment being received in cash. 187,177,232 6% Cumulative Redeemable Preference Shares of Re.1 each allotted as fully paid bonus shares, to the equity share holders, by capitalization of Capital Redemption reserve.

NET WORTH
NET WORTH 8596 6962 5356 4654 3647 3093 2177 929 1271 1695

CASH FLOW STATEMENT FOR THE YEAR ENDED 31st MARCH 2009
Year ended 31st March, 2008 Rs in Million Net Cash From Operating Activities Net Cash Used In Investing Activities Net Cash Used In Financing Activities 11,540.5 6,603.7 (3,256.7) Year ended 31st March, 2008 Rs in Million 10,324.9 7,434.9 (60.6)

Cash and cash equivalent at the end of the year

12,537.6

9,773.1